Max Chan
Directeur Financier/CFO chez FORESEE PHARMACEUTICALS CO., LTD.
Postes actifs de Max Chan
Sociétés | Poste | Début | Fin |
---|---|---|---|
JHL BIOTECH, INC. | Comptroller/Controller/Auditor | 20/10/2015 | - |
Directeur Financier/CFO | 20/10/2015 | 01/05/2018 | |
FORESEE PHARMACEUTICALS CO., LTD. | Directeur Financier/CFO | 07/10/2019 | - |
Public Communications Contact | 07/10/2019 | - | |
Himax Taiwan, Inc. | Directeur Financier/CFO | 08/03/2010 | - |
Himax Media Solutions, Inc. | Directeur/Membre du Conseil | 08/03/2010 | - |
Himax Imaging Ltd. | Directeur/Membre du Conseil | 08/03/2010 | - |
Wisepal Technologies, Inc.
Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Directeur/Membre du Conseil | 08/03/2010 | - |
Harvest Investments Ltd. | Directeur/Membre du Conseil | 09/12/2010 | - |
Himax Semiconductor Ltd. | Directeur/Membre du Conseil | 09/12/2010 | - |
Historique de carrière de Max Chan
Anciens postes connus de Max Chan
Sociétés | Poste | Début | Fin |
---|---|---|---|
OBI PHARMA, INC. | Directeur des opérations | 01/01/2010 | - |
Directeur Financier/CFO | 01/01/2010 | 01/01/2019 | |
Public Communications Contact | 01/01/2010 | 01/01/2019 | |
Corporate Officer/Principal | 01/01/2010 | - | |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Max Chan
University of Illinois | Graduate Degree |
National Taiwan University | Masters Business Admin |
Statistiques
Internationale
Taïwan | 13 |
Etats-Unis | 3 |
Royaume-Uni | 2 |
Opérationnelle
Director of Finance/CFO | 6 |
Director/Board Member | 5 |
Corporate Officer/Principal | 4 |
Sectorielle
Health Technology | 5 |
Electronic Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
INTEL CORPORATION | Electronic Technology |
HIMAX TECHNOLOGIES, INC. | Electronic Technology |
OBI PHARMA, INC. | Health Technology |
FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
Entreprise privées | 10 |
---|---|
CDIB Capital Group
CDIB Capital Group Investment ManagersFinance CDIB Capital Group engages in the venture capital, and investment banking industries. Its business activities include industrial investment, asset management, own capital investment assets, activated assets, and international investment. The company was founded in 1959 and is headquartered in Taipei, Taiwan. | Finance |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Wisepal Technologies, Inc.
Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Distribution Services |
Harvest Investments Ltd. | |
Himax Imaging Ltd. | |
Himax Media Solutions, Inc. | |
Himax Taiwan, Inc. | |
Himax Semiconductor Ltd. | |
Credit Suisse First Boston Asia International (Cayman) Ltd. | |
Eden Biologics, Inc.
Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |